Docaravimab
Based on 1 Customer Validation
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.27%
- CAS No.: 2247196-23-0
- Masse moléculaire:146.48 kDa
-
Stockage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Isotype
Mouse IgG2b kappa
Recommend Isotype Controls
Species Reactivity
Rabies lyssavirus
IC50 & Target
ERA
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG2b-kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized human Rabies virus Glycoprotein G His Tag can bind Docaravimab. The EC50 for this effect is 12.13 ng/mL.
Chemical Information
-
CAS No. 2247196-23-0
-
Appearance Liquid
-
Masse moléculaire 146.48 kDa
-
Color Colorless to light yellow
-
SMILES
[Docaravimab]
-
Synonyms
62-71-3
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)